chevron_leftBack
As of 14 June 2026, Shanghai OPM Biosciences Co., Ltd. has a market cap of $1.06B USD, ranking #10373 globally and #2888 in China.
It ranks #922 in the Healthcare sector, and #344 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$1.06BUSD
7.21B CNY
Enterprise Value
$920.5MUSD
6.23B CNY
Revenue (TTM)
$52.38MUSD
354.91M CNY
EBITDA (TTM)
$11.6MUSD
78.5M CNY
Net Income (TTM)
$6.15MUSD
41.7M CNY
EBITDA Margin
22%
Profit Margin
12%
PE Ratio
139.9
Forward PE
79.6
PS Ratio
20.3
PB Ratio
3.4
EV/EBITDA
76.4
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Zhihua Xiao
open_in_new
Employees
64
Founded
2013
Website
opmbio.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -2.9% | 4.1% | 16% | 0.8% | -17% | 23% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
688293
上海奥浦迈生物科技股份有限公司 Class A
ISIN: CNE100005PF1
Shares Out.:
Shares Outstanding:
113.82M1
Shares Float:
40.323M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
50.24 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Shanghai OPM Biosciences Co., Ltd.
Shanghai OPM Biosciences Co., Ltd. provides cell culture media and CDMO services in China and internationally. The company offers cell culture media and feed supplements, such as OPM's CHO-Platform, OPM-293 Platform, and VegaCHO media and feeds, as well as customized cell culture media development services. It also provides end-to-end biologics CDMO services, such as antibody discovery, stable cell line development, cell banking, upstream process development, downstream process development, formulation development, and quality control and product characterization of biologics. The company was founded in 2013 and is headquartered in Shanghai, China.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SSE: 600276
|
$53.85B
5K%
364.89B CNY
|
44.9
|
|
SSE: 603259
|
$49.64B
5K%
336.36B CNY
|
17.2
|
|
SHEK: 3692
|
$28.52B
3K%
223.48B HKD
|
35.7
|
|
SHEK: 1801
|
$18.8B
2K%
147.32B HKD
|
162.3
|
|
SSE: 688506
|
$16.51B
1K%
111.89B CNY
|
-
|
|
SHEK: 9926
|
$16.01B
1K%
125.46B HKD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
71K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
51K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
34K%
|
97.4
|
|
SIX: RO
|
$321.52B
30K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$288.84B
27K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$274.65B
26K%
218.9B CHF
|
20.5
|
chevron_leftBack